Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.
about
Clinical significance of sCD163 and its possible role in asthma (Review).Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferonCirculating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver DiseaseChronic hepatitis C infection-induced liver fibrogenesis is associated with M2 macrophage activation.The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients.The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation.Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection.Macrophage activation marker, soluble CD163 is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients.Discovery of a Potential Plasma Protein Biomarker Panel for Acute-on-Chronic Liver Failure Induced by Hepatitis B Virus.Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study
P2860
Q33674640-BBFD54C4-E349-4721-B9F2-1443F0162849Q33877898-0D448BD7-DA32-47E9-B789-E8948830B725Q36751382-098DFF4C-EB90-4A7C-9C74-41BE197035FEQ37522434-C56D07DB-FA4A-4FCF-8190-00DEF8780A3FQ40337789-E5E7A063-AF7E-4A7E-9D16-1E8629FE89A4Q40495697-8EAC54D6-6C3C-43F7-AEAD-8E773C86E185Q40671632-E2652129-FC9C-4F3D-BEBF-5313905250A1Q40734458-CC4F7658-06E4-4B34-B1F1-788B2CE1AC77Q41757581-9B2C1FAC-CD74-4DD7-A485-8A219A79754AQ47132141-855CB0E9-0F15-4A21-AAA1-ACBE8EF888C2Q47158621-81590DE7-D818-4226-8E60-8169113FB700Q47266129-88679EB6-DF3B-4EFE-B1D8-67D904E4895BQ58706878-27D125A0-A02D-4933-BBF3-D793D206399A
P2860
Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Macrophage-related serum bioma ...... ic hepatitis C: a pilot study.
@en
Macrophage-related serum biomarkers soluble CD163
@nl
type
label
Macrophage-related serum bioma ...... ic hepatitis C: a pilot study.
@en
Macrophage-related serum biomarkers soluble CD163
@nl
prefLabel
Macrophage-related serum bioma ...... ic hepatitis C: a pilot study.
@en
Macrophage-related serum biomarkers soluble CD163
@nl
P2093
P2860
P50
P1476
Macrophage-related serum bioma ...... ic hepatitis C: a pilot study.
@en
P2093
B Moessner
E S Andersen
S Rødgaard-Hansen
P2860
P2888
P304
P356
10.1007/S10096-013-1936-3
P577
2013-08-10T00:00:00Z
P6179
1050272404